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A B S T R A C T
MRSI in the brain at ≥7 T is a technique of great promise, but has been limited mainly by low B0/B1
+-
homogeneity, speciﬁc absorption rate restrictions, long measurement times, and low spatial resolution. To
overcome these limitations, we propose an ultra-high resolution (UHR) MRSI sequence that provides a
128×128 matrix with a nominal voxel volume of 1.7×1.7×8 mm3 in a comparatively short measurement time. A
clinically feasible scan time of 10–20 min is reached via a short TR of 200 ms due to an optimised free induction
decay-based acquisition with shortened water suppression as well as parallel imaging (PI) using Controlled
Aliasing In Parallel Imaging Results IN Higher Acceleration (CAIPIRINHA). This approach is not limited to a
rectangular region of interest in the centre of the brain, but also covers cortical brain regions. Transversal pulse-
cascaded Hadamard encoding was able to further extend the coverage to 3D-UHR-MRSI of four slices
(100×100×4 matrix size), with a measurement time of 17 min. Lipid contamination was removed during post-
processing using L2-regularisation. Simulations, phantom and volunteer measurements were performed. The
obtained single-slice and 3D-metabolite maps show the brain in unprecedented detail (e.g., hemispheres,
ventricles, gyri, and the contrast between grey and white matter). This facilitates the use of UHR-MRSI for
clinical applications, such as measurements of the small structures and metabolic pathologic deviations found in
small Multiple Sclerosis lesions.
1. Introduction
Proton magnetic resonance spectroscopic imaging (MRSI) in the
brain is a powerful non-invasive metabolic imaging modality that
enables an investigation of the spatial distribution of multiple meta-
bolites simultaneously. Apart from the application for basic research,
the detection of metabolic changes caused by brain tumours, epilepsy,
Multiple Sclerosis (MS) or other neurodegenerative diseases can assist
in clinical research and diagnosis (Hetherington et al., 2014; Pan et al.,
2013; Ratai et al., 2008; Srinivasan et al., 2010). Particularly for the
investigation of the spatially heterogeneous composition of glioma in
particular in the inﬁltrative form and MS lesions that typically have
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dimensions in the range of only 3–6 mm, the resolution of previous
MRS and MRSI methods was insuﬃcient. Thus, increasing the resolu-
tion of MRSI is an important step toward increasing the clinical utility.
Ultra-high ﬁeld MR systems (i.e., ≥7 T) oﬀer signiﬁcant advantages for
MRSI that can be used to that end, but before these can be fully
exploited several limitations must be addressed.
1.1. Advantages and limitations of MRSI at ≥7 T
MRSI beneﬁts from higher B0 due to an increased signal-to-noise
ratio (SNR) that can be translated into higher spatial resolutions or
faster measurements. The increased spectral dispersion facilitates the
separation and quantiﬁcation of neighbouring resonances (Moser et al.,
2012).
At ≥7 T, MRSI suﬀers from more pronounced constraints compared
to lower B0 (Moser et al., 2012) including speciﬁc absorption rate
(SAR) restrictions, shorter T2s that penalise the use of long echo times
(TEs), lower B0/B1
+-homogeneity that decreases spectral quality and
complicates water/lipid-suppression, and larger chemical shift displa-
cement errors (CSDEs). In addition, the general limitations of conven-
tional MRSI sequences apply: point-spread functions (PSF) for low
matrix sizes lead to poor slice proﬁles, subject movement and long
measurement times.
1.2. 7 T MRSI – state of the art
Previous research has addressed these constraints. The signal loss
to T2-relaxation and J-evolution can be overcome by shortening the TE
(Avdievich et al., 2009; Boer et al., 2011) or by direct free induction
decay (FID-)acquisition (Bogner et al., 2012; Henning et al., 2009).
Localisation by semi-localized adiabatic selective refocusing (semi-
LASER) (Scheenen et al., 2008) or point-resolved spectroscopy
(PRESS) (Balchandani et al., 2008; Xu et al., 2008) were successfully
adapted to 7 T, but are limited to a region of interest (ROI) in the
centre of the brain.
Non-Cartesian trajectories such as spiral MRSI (Andronesi et al.,
2012) or echo-planar spectroscopic imaging (EPSI) (Lecocq et al.,
2014) accelerate measurements considerably at lower ﬁeld strengths
(≤3 T), but the increased spectral bandwidth requirements at ≥7 T has
limited the achievable resolutions. Thus far, EPSI was only applied to
systems with specialised, stronger head gradient systems (Otazo et al.,
2006). Parallel imaging (PI) is another option for measurement
acceleration, which beneﬁts from ≥7 T (Wiesinger et al., 2004).
Sensitivity-encoding (SENSE) (Kirchner et al., 2015; Zhu et al.,
2013) as well as generalized autocalibrating partially parallel acquisi-
tions (GRAPPA) (Hangel et al., 2015), have thus far been demonstrated
for 7 T.
Lipid suppression for 7 T was adapted in the context of higher SAR
demands and ﬁeld inhomogeneities. While high in-plane resolutions
and Hamming ﬁltering can reduce lipid contamination via improve-
ment of the PSF (Bogner et al., 2012), several sequence-based lipid
suppression schemes were proposed, such as FIDLOVS (FID acquisi-
tion, Localized by Outer Volume Suppression) (Henning et al., 2009),
SWAMP (Sequence for Water suppression [WS] with Adiabatic
Modulated Pulses) extended to simultaneous lipid/water suppression
(Boer et al., 2011), spatial-spectral adiabatic inversion pulses
(Balchandani and Spielman, 2008), simultaneous water/lipid suppres-
sion using adiabatic full-passage pulses (Zhu et al., 2013) or non-
selective double inversion recovery-based lipid suppression (Hangel
et al., 2015). These methods typically require long TRs, are limited to a
restricted ROI inside the brain or reduce SNR. Additional hardware
(Boer et al., 2015; Hetherington et al., 2010) allows further improved
lipid suppression with fewer limitations for the sequence itself, but is
not widely available. Higher-order shims (Hetherington et al., 2014;
Pan et al., 2012) or parallel transmit systems (Boer et al., 2012; Emir
et al., 2012) greatly improve B0- and B1
+-homogeneity. These sub-
stantially support (frequency-selective) suppression techniques.
Multi-slice MRSI is often desirable to cover the entire brain region
of interest. To avoid an excessive increase in measurement time, and
reduction in B0-homogeneity over large volumes at ≥7 T, the covered
ROI is often kept as small as possible. However, the sampling of only
few slices (e.g. 2–8) via phase encoding provides only poor localisation
due to the PSF. Alternatively, interleaved slice-selective multi-slice
MRSI (Boer et al., 2012) was proposed for 7 T. Another approach is
slice encoding via a pulse-cascaded Hadamard scheme (Goelman et al.,
2007). This provides higher SNR than interleaved single-slice acquisi-
tions and oﬀers better slice proﬁles than phase encoding.
1.3. Purpose
We propose a high-resolution FID-acquisition sequence for ultra-
high resolution (UHR)-MRSI at 7 T. Combined TR reduction and PI
shorten measurement times to an extent that makes UHR-MRSI
clinically feasible. Pulse-cascaded Hadamard encoding allows the
expansion to 3D-UHR-MRSI. This allows the visualisation of biochem-
ical changes in the brain in unprecedented detail, e.g. in order to
resolve small Multiple Sclerosis lesions.
2. Materials and methods
2.1. Subjects and hardware
Seven healthy volunteers (ﬁve males, two females; median age, 28
years; range, 26–34 years) participated in this study. Institutional
Review Board approval and written, informed consent were obtained.
We performed measurements on a 7 T whole-body MR scanner
(Magnetom, Siemens Healthcare, Erlangen, Germany) with a
7T_SC72CD gradient system with 70 mT/m total gradient strength
and 200 mT/m/s nominal slew rate. A head coil with a 32-channel
receive coil array combined with a volume coil for transmission (Nova
Medical, Wilmington, MA, USA) was used.
2.2. Sequence design
Our main design goal was the acceleration of MRSI scans to realise
single-slice and 3D UHR metabolic mapping in clinically feasible scan
times. This was accomplished by a) reducing the minimum TR via
shortened water suppression and signal readout, b) eﬃcient parallel
imaging (Strasser et al., 2016) and c) pulse-cascaded Hadamard
encoding (Goelman et al., 2007) for 3D coverage.
The resulting FID-MRSI sequence was similar to earlier approaches
(Bogner et al., 2012; Strasser et al., 2013), but allowed a shorter TR of
200 ms, matrix sizes up to 128×128 and up to four Hadamard-encoded
slices. The ultra-short AD of 1.3–4.3 ms (depending on the slice) led to
a high SNR due to negligible T2-decay and J-modulation. As the short
TR did not allow for extensive lipid-suppression schemes, lipid
contamination was removed using L2-regularisation (Bilgic et al.,
2013) during post-processing.
2.2.1. TR reduction
Originally, the WET (Water suppression Enhanced through T1
eﬀects) scheme (Ogg et al., 1994) was designed for 1.5 T as insensitive
to variations in B1
+ and T1 relaxation. This WET scheme had to be
adapted for our 7 T system. The WET module is typically implemented
using three sub-modules (each consisting of a 9 ms Gauss suppression
RF pulse with a bandwidth of 100 Hz and a 51 ms spoiler gradient for a
total duration τ of 60 ms). This results in a total WS duration of
180 ms. The increased gradient performance of our scanner allowed a
substantially reduced τ (i.e., tested for values ranging from 10 to
60 ms). In addition, we implemented a 4th suppression pulse as
proposed by (Ogg et al., 1994) to increase the suppression stability
(deﬁned by the residual water magnetisation for a variation of B1
+ of ±
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15%) to compensate for the increased B1
+-inhomogeneities at 7 T.
As a second step, we reduced the readout duration by decreasing
the number of sampling points (including overampling) from 2048 to
1024 and using a shorter dwell time of 111 µs (i.e., 9000 Hz readout
bandwidth), resulting in a readout duration of 113 ms compared to the
prior 343 ms.
Thereby, TRs in the range of 200 ms could be realised, as depicted
by the sequence scheme in Fig. 1A.
2.2.2. Parallel Imaging - CAIPIRINHA
The application of CAIPIRINHA (Controlled Aliasing In Parallel
Imaging Results IN Higher Acceleration) (Strasser et al., 2016) allowed
a further reduction of measurement times. In contrast to traditional
GRAPPA-based parallel imaging, which leaves out entire lines in k-
space, CAIPIRINHA leaves out more complicated k-space pattern to
improve the reconstruction eﬃciency. In both cases the missing k-
space points are then reconstructed using information from the array
coil and additionally acquired autocalibration signal lines. Our im-
plementation of CAIPIRINHA acquires autocalibration signal prescans
via a rapid gradient echo sequence, in ~one second with low g-factors
for accelerations ≤9 (Hangel et al., 2015).
2.2.3. Ultra-high resolution
By decreasing TR from ~600–1500 ms to 200 ms and accelerating
by ~9 via CAIPIRINHA, a total acquisition acceleration of ~30–70-fold
can be achieved. This allowed MRSI matrix sizes of 128×128 (i.e.,
nominal in-plane resolution of 1.7×1.7 mm2 and a nominal voxel
volume of 23 µl) to be realized in clinically feasible measurement times.
2.2.4. Hadamard spectroscopic imaging
Multi-slice MRSI was implemented via transverse pulse-cascaded
Hadamard encoding to overcome limitations of conventional
Hadamard spectroscopic imaging (HSI) with superimposed selection
pulses at ≥7 T (Goelman et al., 2007). This approach reduced SAR
requirements and CSDEs by playing out the selective RF pulses in the
HSI encoded direction in rapid succession. The modiﬁcation of the
MRSI sequence for HSI is displayed in Fig. 1B. In general, transverse
HSI allows the measurement of 2 n slices (n=1,2,3 …) by simulta-
neously selecting all these slices and repeating each excitation 2 n-times
with diﬀerent excitation phase settings. The individual slices can be
later separated with a special subtraction/addition scheme that is
determined by the Hadamard matrix.
2.3. Simulations and parameter optimisation
We simulated the steady-state magnetisation for N-acetyl-aspartate
(NAA), creatine (Cr), choline (Cho), glutamate (Glu) and myo-inositol
(Ins), for the TRs of 200 ms, 600 ms, and 1500 ms to estimate the
change in the signal ratios between metabolites (i.e., Cr/NAA, Cho/
NAA, Glu/NAA, Ins/NAA) for diﬀerent TRs. The calculations were
based on reported T1 values (Xin et al., 2013). The optimal average ﬂip
angle (FA)/Ernst angle for the main metabolites was calculated as
geometric average (Bottomley and Ouwerkerk, 1994). The relative SNR
and sensitivity calculations were based on studies by (Pohmann et al.,
1997).
2.4. Measurement protocols
The in vivo MRSI protocols included additional MRI scans:
MP2RAGE (magnetization-prepared 2 rapid acquisition gradient
echoes) (Marques et al., 2010) with a 4:39 min scan time, and a pre-
saturation turbo-FLASH-based B1
+-mapping sequence (Chung et al.,
2010; Klose, 1992) to optimise the eﬀective MRSI excitation FA.
Second-order ﬁeld map-based B0-shimming was used. CAIPIRINHA
calibration data and receiver noise-prescans were integrated into the
MRSI sequences and were utilised for PI reconstruction (Hangel et al.,
2015) and coil combination (Strasser et al., 2013). In total, imaging,
shimming, and ﬁeld of view (FOV) placement (typically placed
transversally above the ventricles) required around 15–20 min.
All MRSI protocols shared the following settings: AD of 1.3 ms (i.e.,
1.3–4.3 ms for 4-slice HSI); FOV of 220×220 mm2; 10 mm slice
thickness for single slice and 8 mm for multi-slice scans; elliptical k-
space sampling with a spiral-like scheme starting at the k-space centre;
three-lobe SINC excitation pulses with 0.6 ms duration and a ﬂip angle
of 29° for TR 200 ms (calculated B1:9.14 µT) and 45° for TR 600 ms
(calculated B1:14.18 µT). WET water suppression was implemented
with a four-pulse scheme and a 100 Hz pulse bandwidth, with a total
duration of 64 ms. Five main protocols were used to evaluate in vivo
MRSI protocols (Tbl. 1). Five in vivoMRSI protocols were deﬁned (Tbl.
1). Further protocols for validation of water suppression and HSI
performance are described in the subsections 2.4.1 and 2.4.3.
2.4.1. Volunteer measurements – Water suppression
To exclude any negative eﬀects due to shortening of the WS module,
ﬁxed MRSI sequence parameters (i.e., 32×32 matrix, TR 600 ms, and
acceleration R of 9, 1:09 min) were used for diﬀerent WS settings: no
WS; three pulse-WS (τ 60 ms; total duration 180 ms); and four pulse-
WS (variable τ of 10, 11, 12, 15, 20, 30, 40, 50 and 60 ms; total





the water peak for each voxel, averaged over the whole slice and
compared between the diﬀerent WS scans. The spectral quality was
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Fig. 1. UHR-FID-MRSI scheme (not to scale) for A) a single slice, and B) Hadamard-
encoded multi-slice utilising cascaded excitation, with one excitation pulse per slice.
Optimised use of the gradient system, together with a shorter readout window and the
FID approach allow TRs in the range of 200 ms. The acquisition delay is deﬁned from the
centre of the excitation pulse to the readout start.
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2.4.2. Volunteer measurements – Single-slice UHR
In order to test the feasibility of the proposed UHR-MRSI sequence
in vivo, we measured three volunteers (all male; 34, 34, 27 y) with the
fully sampled UHR protocol #1-“1SL_ M128_TR200” (Table 1). The
resulting datasets were reconstructed without undersampling as well as
with artiﬁcial undersampling using 2D-CAIPIRINHA acceleration by a
factor of 2, 3, 4, 5, 6 and 8. The quality of metabolic maps with diﬀerent
acceleration factors was compared.
In order to evaluate the impact of the changed TR and resolution on
spectral quality, we compared results obtained with protocol #1-“1SL_
M128_TR200” with those obtained in two volunteers with protocol #2-
“1SL_M64_TR600” and protocol #3- “1SL_M64_TR200” (Tbl. 1).
2.4.3. Phantom scans – HSI SNR and localisation
To investigate the slice localisation properties of our Hadamard
encoding module, we conducted three phantom experiments.
a) Slice proﬁles were measured in a cylindrical phantom ﬁlled with
MACROL oil. The cascaded pulse scheme was inserted into a spin-
echo sequence (TR 20 s, TE 300 ms, and 10 mm slice thickness, 90°
ﬂip angle) that excited a whole slice and read out the spatial
excitation proﬁle using a z-gradient during readout. Four-slice HSI
measurements were conducted with adjacent slices, as well as gaps
between the slices of 50, 100, 200, and 300% of the slice thickness.
As a comparison, four adjacent individual slices with four averages
were measured. The resulting pulse proﬁles and the signal bleed
into the other slice positions were evaluated.
b) Signal bleeding between slices was assessed in a cylindrical
phantom with compartments. A small compartment was ﬁlled with
a creatine (Cr) solution, while the adjacent compartments contained
a 5% acetate (Ac) solution (relative concentration Ac:Cr ~5:1). A
single-slice MRSI scan placed in the Cr compartment was compared
to HSI-MRSI with adjacent slices or a 100% slice gap (32×32-
matrix and 5 mm slice thickness for all three) that had one of the
middle slices in the same position as the single slice. For reference,
a single slice in the Ac compartment was measured. The contam-
ination was calculated as the ratio of the Ac signal of the slice in the
Cr compartment to the Ac signal in the Ac compartment reference
slice.
c) The third measurement determined the eﬀective SNR gain com-
pared to single-slice (1SL-)MRSI. HSI and 1SL-MRSI (42×42
matrix, 8:24 minutes measurement time per slice) were measured
with the single slice and HSI-slice #3 placed identically in the Cr
compartment. The average Cr SNR was compared.
2.4.4. Volunteer measurements – HSI-UHR
To test the feasibility of multi-slice acquisition, we measured
protocol #5- “4SL_M100_TR200” (Tbl. 1) in all ﬁve volunteers. Due
to practical constraints of SNR and measurement time feasibility in
clinical settings, we chose an acceleration factor of 6 with a reduced
matrix size of 100×100×4 to remain below < 17 min scan time. With a
slice gap of 2 mm between the slices, this resulted in an FOV of
220×220×38 mm3. Considering the SNR gain due to HSI and increased
voxel size, but with the reduced amount of encoding steps, we expected
an SNR-increase of 5% compared to the previous un-accelerated
protocol #1-“1SL_ M128_TR200” under optimal conditions. This
was evaluated experimentally by comparing protocol #1-“1SL_
M128_TR200” and #5-“4SL_M100_TR200”. Robustness and quality
were validated as before (2.4.2), with a focus on the resulting
metabolite and metabolic ratio maps.
2.5. Data processing
For oﬄine MRSI data processing, we used an in-house-developed tool
(Považan et al., ISMRM 2015, Nr. 1973) based on Matlab (R2013a,
MathWorks, Natick, MA, USA), Bash (version 4.2.25, Free Software
Foundation, Boston, MA, USA), and MINC (MINC tools, v2.0,
McConnell Brain Imaging Center, Montreal, QC, Canada). MUSICAL
(multichannel spectroscopic data combined by matching image calibra-
tion data) coil combination (Strasser et al., 2013), CAIPIRINHA recon-
struction, and a spatial Hamming ﬁlter were applied. No apodisation ﬁlter
or zero ﬁlling was used. Spectral ﬁtting of the spectral range between 1.8
and 4.0 ppm used LCModel (Provencher, 2001) and included a measured
macromolecule background in the basis-set (Považan et al., 2015).
Possible lipid contamination of the spectra was removed utilising L2-
regularisation (Bilgic et al., 2013). The resulting metabolite maps were
interpolated spatially by a factor of two.
2.6. Data evaluation
NAA SNR values were calculated via an adapted pseudo-replica
method (Robson et al., 2008). Noise was assessed via the standard
deviation of a Gaussian noise matrix generated for each coil channel,
which was processed like the MRSI data. The signal amplitude was
deﬁned as the NAA peak heights of the LCModel estimation. The SNR
values of all protocols with a TR 200 of ms were then corrected relative
to protocol #2-“1SL_M64_TR600” by a factor of 1
3
to account for an
overestimation in the SNR calculation due to the diﬀerent bandwidth
and number of sampling points. The mean and standard deviation of
NAA SNR, full width at half maximum (FWHM) and Cramér-Rao lower
bounds (CRLBs) over all brain voxels of a scan protocol were compared
between the protocols.
3. Results
3.1. Simulation and parameter optimisation
The optimal average FA for a TR of 200 over all metabolites was
29°. The average magnetisation over all simulated metabolites was
reduced to 58 ± 1% compared to a TR of 600 ms and to 38 ± 1%
compared to a TR of 1500 ms. The highest change in ratios was
between NAA and 3.9 ppm Cr, with a decrease of 2.5% from 600 to
200 ms and 4.3% from 1500 to 200 ms. Therefore, the expected change
in the ratios between metabolites had only a negligible impact. While
the SNR per excitation for NAA decreased to 58% of its value at a TR of




⎠⎟ remained the same (i.e., 100% of that
obtained via protocol #1-“1SL_M64_TR600”).
Table 1
Overview of the MRSI measurement protocols used and their relevant differences. The protocol names defined here are used in the whole text. R is the CAIPIRINHA acceleration factor.
The in-plane FOV for all protocols was 220 mm×220 mm. For the TR 200 ms protocols, an excitation ﬂip angle of 29° and an ADC with 1024 complex sampling points/9000 Hz readout
bandwidth was used. For the TR 600 ms protocols, a ﬂip angle of 45° and 2048 points/6000 Hz was used.
Protocol Matrix TR [ms] R Duration [min] Volunteers Nominal resolution [mm3]
#1 1SL_M128_TR200 128×128 200 1 42 3 1.7×1.7×10
#2 1SL_M64_TR600 64×64 600 4 7.5 2 3.4×3.4×10
#3 1SL_M64_ TR200 64×64 200 4 2.5 2 3.4×3.4×10
#4 4SL_M64_ TR200 64×64×4 200 6 7 5 3.4×3.4×8
#5 4SL_M100_TR200 100×100×4 200 6 17 5 2.2×2.2×8
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Table 2
Mean NAA SNR, FWHM, and CRLB over all SSL and HSI volunteers. While the lower TR does not affect the SNR, FWHM and CRLB worsen due to the reduced spectral sampling. The
sensitivity (here normalised to the square root of one hour) increases for the shorter TR, as it could be expected for more excitations in the same time. For different CAIPIRINHA
accelerations of the UHR, sensitivity decreased by only a small amount due to noise enhancement.
Protocol NAA SNR Sensitivity [1/ h ] FWHM [Hz] CRLB [%]
1SL 1SL_M64_TR600 R4 39 ± 13 110 ± 37 13 ± 4 4 ± 4
1SL_M64_TR200 R4 22 ± 7 107 ± 35 18 ± 4 10 ± 5
1SL_M128_TR200 R1 23 ± 8 27 ± 10 17 ± 5 10 ± 5
1SL_M128_TR200 R2 16 ± 6 27 ± 10 19 ± 5 11 ± 5
1SL_M128_TR200 R3 12 ± 5 26 ± 10 20 ± 5 13 ± 5
1SL_M128_TR200 R4 10 ± 4 25 ± 9 21 ± 5 14 ± 6
1SL_M128_TR200 R5 9 ± 4 25 ± 10 21 ± 5 15 ± 6
1SL_M128_TR200 R6 8 ± 3 25 ± 10 22 ± 5 16 ± 7
1SL_M128_TR200 R8 7 ± 3 25 ± 10 23 ± 6 17 ± 6
HSI 4SL_M64_TR200 R6 29 ± 11 247 ± 94 20 ± 6 9 ± 5
4SL_M100_TR200 R6 19 ± 7 66 ± 26 13 ± 4 12 ± 6
A-128/R1 B-128/R4
C-64/TR200 D-64/TR600
Chemical Shift (ppm) Chemical Shift (ppm)
  4.0     3.0     2.0     3.8     1.8     2.2     2.4     2.6     2.8     3.2     3.4     3.6   
  1.8     4.0     3.0     2.0     3.8     2.2     2.4     2.6     2.8     3.2     3.4     3.6   
Chemical Shift (ppm) Chemical Shift (ppm)
4.0     3.0     2.0     3.8     1.8     2.2     2.4     2.6     2.8     3.2     3.4     3.6   
4.0     3.0     2.0     3.8     1.8     2.2     2.4     2.6     2.8     3.2     3.4     3.6   
Fig. 2. Comparison of voxel spectra of the same occipital lobe WM location (note that UHR voxels are smaller by a factor of four) in the 1.8–4.0 ppm range, all with an acquisition delay
of 1.3 ms. For the TR 200 ms protocols, a readout with 1024 sampling points/9000 Hz bandwidth was used and for the TR 600 ms protocol 2048 points/6000 Hz. Black is the measured
spectrum and red the LCModel-ﬁtted metabolite resonances. The spectra were ﬁrst-order phased for better visibility. A) Shows the non-accelerated UHR scan, b) the same scan
artiﬁcially accelerated by a factor (R) of 4, C) the comparison measurement with the same TR of 200 ms and D) the comparison measurement with a TR of 600 ms. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article).
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3.2. Volunteer measurements – Water suppression
The evaluation of WS eﬃciency showed a similar average remaining
water signal of 0.99 ± 0.58% to 1.47 ± 0.95% for τs of 15–60 ms of the
shortened four-pulse scheme (Supplementary Fig 1a). The longer
three-pulse scheme resulted in an average of 0.99 ± 0.46%. For τ <
15 ms, water sideband artefacts compromised the spectral quality
(Supplementary Fig 1b). Therefore, with a τ of 15 ms, WS duration
could be minimised, with no loss of WS performance (1.14 ± 0.65%
remaining water signal).
3.3. Volunteer measurements – Single-slice UHR
The average SNR values (Table 2) of protocol #1-“1SL_
M128_TR200” and protocol #3-“1SL_ M64_TR200”, were very simi-
lar (23 ± 8 and 22 ± 7 respectively), as expected when accounting for
the voxel volume, the encoding steps ( × 4 × 4 )14 and acceleration
compared to protocol #3-“1SL_ M64_TR200“. The relative sensitivity
was aﬀected only by the diﬀerent voxel volumes. Comparing protocols
#1-“1SL_ M128_TR200” and #2-“1SL_M64_TR600”, with the same
factors for volume, encoding, and acceleration, there was a reduction of
the SNR to 59%, very close to our simulation result of 58%. The relative
sensitivity was slightly lower than the simulation (i.e., 97%). The
reduction of sampling points from 2048 to 1024 over −5 ppm to 10 pm
aﬀected the measured FWHM and CRLB values while the voxel volume
did not. Sample spectra (Fig.2) show that despite the reduced spectral
sampling, the spectral information of UHR spectra remained similar.
Metabolic maps obtained with protocol #1-“1SL_ M128_TR200”
reached a level of anatomical detail that showed gyri as well as the
cortical sulci with an excellent GM/WM diﬀerentiation (Fig. 3), which
was not possible with the 64×64 matrix. The Glx-maps and also the
ratio maps showed an excellent grey matter/white matter (GM/WM)
contrast as displayed in Fig. 4 for all volunteers. Bland-Altman plots
that compare the metabolite ratio of the protocols #2-
“1SL_M64_TR600” and #3-“1SL_ M64_TR200“ (supplementary ﬁg-
ure 3) show that the ratios of tNAA and Glx to tCr remain stable when
reducing the TR, but deviate for Ins and Cho.
The potential for measurement acceleration depends on the choice
of metabolites that have to be reliably quantiﬁed (Fig. 5). While NAA
oﬀered enough signal to be accelerated by a factor of 6 (Tbl. 2), J-
coupled metabolites, which are more challenging to detect, such as Ins
or Glu, allowed acceleration by only 2–3-fold (i.e., ~13–20 min scan
time).
3.4. Phantom scans – HSI SNR and localisation
Slice proﬁle measurements showed comparable slice proﬁles for
single-slice and HSI measurements, with approximately 1–2% residual
contamination per other slice for HSI (Supplementary Fig 2). Imperfect
slice proﬁles for adjacent HSI slices required a small slice gap (25–
50%) for in vivo measurements to avoid crosstalk between adjacent
slices. Phantom experiments showed an Ac contamination of 6.4 ±
0.7% for the single-slice, 6.8 ± 0.6% for adjacent HSI, and 6.5 ± 1.1%
for HSI with a slice gap. This indicated that the contamination for HSI
was similar to that of a single slice measurement. The SNR of the four-
slice HSI scan was 1.90 ± 0.30 higher than for the single-slice scan (i.e.,
close to the optimal factor of two).
3.5. Volunteer measurements – HSI-UHR
The average SNR for #5-“4SL_M100_TR200” of 19 ± 9 (Tbl. 2)
compared to protocol #1-“1SL_ M128_TR200” was 17% lower rather
than 5% higher, as we had estimated under 2.4.4. Therefore, the
eﬀective SNR-increase for HSI between protocol #1-“1SL_
M128_TR200” and #5-“4SL_M100_TR200” was less than expected
with a factor of 1.6 (an optimal factor of 2 was expected for four slices).
The mean NAA CRLBs were 12 ± 5%. The comparison of UHR- and the
64×64 resolution reference measurement in one volunteer (Fig. 6)
showed the increased metabolic map quality that can be already
obtained with a 100×100 matrix. This map quality was reproducible
over all volunteers (Fig. 7). The metabolite and metabolic ratio maps of
another volunteer (Fig. 8) showed that HSI-UHR-MRSI provides
Fig. 3. UHR metabolite maps of one volunteer (without acceleration, measured, in decreasing order in 42, 2.5, and 7.5 min) show much greater correspondence to anatomical detail
than the comparison maps, as in the cortical sulci or gyri, with tNAA=NAA+N-acetyl-aspartyl glutamate (NAAG), tCr=Cr+phosphocreatine (PCr), tCho=choline-containing compounds,
Glx=Glu+glutamine (Gln). A zoom-in of the Glx-map highlights the visibility of the GM/WM contrast. The colours from cold to warm indicate higher relative concentrations, apart from
the apparent concentration diﬀerences between the hemispheres that are most likely the result of the coil sensitivity proﬁle if the subject's head is not exactly in the centre of the coil.
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Fig. 4. UHR metabolic ratio maps of all three SSL volunteers acquired with protocol #1 1SL_M128_TR200 in 42 min. They consistently show a high grade of detail, and in the case of
Glx/tNAA and tCho/tNAA, even a good GM/WM contrast.
Fig. 5. The quality deterioration of the UHR-maps of protocol #1 1SL_M128_TR200 for increasing artiﬁcial acceleration factors (R) from 2 to 8 shows that, while the SNR for NAA is
robust enough to allow higher accelerations, lower-SNR metabolites, e.g., Ins, can be reliably measured only with acceleration factors (R) of up to 2–4, depending on the required
metabolites. This would still reduce the measurement time to 10–20 min, which is suﬃcient for clinical applications.
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visibility of similar anatomical structures and GM/WM contrast similar
to that of 1SL-UHR-MRSI, but provided superior brain coverage.
4. Discussion
The presented phantom and volunteer results show that single- and
multi-slice UHR-FID-MRSI in the brain are feasible at 7 T, and provide
high-resolution metabolic maps in clinically acceptable measurement
times.
4.1. Results in comparison to other research
4.1.1. Acquisition and TR reduction
Improving WET WS timing with shorter gradients allowed shorter
TRs while retaining similar WS quality. Our simulations showed that
the shorter TRs did not lead to a relevant change in metabolite ratios
due to changed T1-weighting (but could be corrected for if desired). In
contrast to FID-MRSI (Boer et al., 2011; Bogner et al., 2012) for ≥7 T,
which allows extremely short TRs due to its simple pulse scheme,
alternatives acquisition approaches like semi-LASER (Scheenen et al.,
2008) or PRESS (Balchandani et al., 2008; Xu et al., 2008) are limited
to an ROI in the centre of the brain and lower matrix sizes. In contrast,
the FID-based approach without outer volume suppression enables
coverage of the whole slice, including locations including the subcor-
tical and cortical regions of the brain.
4.1.2. Acceleration methods
Our results show that acceleration of single-slice MRSI by a factor
of 2–3 is possible with parallel imaging, while retaining enough SNR
for reliable quantiﬁcation of metabolites. Even higher acceleration
factors of up to 6 were reliable for HSI measurements due to the
increased SNR. We previously showed that the use of prescan imaging
data as an auto-calibration signal to accelerate MRSI measurements
with GRAPPA (Hangel et al., 2015) or CAIPIRINHA (Strasser et al.,
2016, Nr. 0651) allowed acceleration factors up to 9 with g-factors <
1.1 than reported for SENSE approaches at 7 T thus far (Kirchner et al.,
2015; Zhu et al., 2013).
Parallel imaging eﬃciency beneﬁts substantially from higher B0 and
improved receive coils (Wiesinger et al., 2004). In contrast, EPSI and
spiral sampling beneﬁt mostly from improved gradient hardware, but
are challenging at higher B0 (e.g., 7 T), even with lower resolution.
While EPSI that measured a 32×32 matrix in 8:32 min with a spectral
BW of 1380 Hz was presented in 2006 (Otazo et al., 2006), this
required a special head gradient (e.g. 80 mT/m, 600 mT/m/ms).
Although recently (Snoussi et al., ISMRM 2015, Nr. 0428) presented
EPSI with a 50×50×18 matrix at 7 T in 25 min and a spectral readout
BW of 2466 Hz, the gradient restrictions of whole-body scanners limit
the SNR eﬃciency compared to 3 T. The combination of both PI and
spectral-spatial sampling could combine the beneﬁts of both (Sabati
et al., 2014).
4.1.3. Ultra-high resolution
To our knowledge, we present the ﬁrst MRSI sequence for human
brain scanning at 7 T in vivo that allows matrix sizes of up to 128×128
and nominal spatial resolutions as low as 23 mm3 within clinically
feasible scan times. At 3 T, where acquisition strategies with advanced
readout trajectories are commonly used due to the lower required
receiver bandwidth, UHR-MRSI has been reported. With a combina-
tion of phase encoded MRSI and EPSI sampling, a 110×110 matrix was
acquired in 15.5 min (Ma et al., 2016), as well as an 80×80×20 matrix
in 26 min (Lam et al., 2015). Furthermore, by using spiral MRSI with a
reduced spectral BW of ~600 Hz (Bhattacharya and Jacob, ISMRM
2015, Nr. 2017), matrix sizes of 96×96 in 3 min and 128×128 in 7 min
were achieved.
4.1.4. Hadamard spectroscopy imaging
While it was necessary to reduce the matrix size to 100×100 for
four-slice HSI to keep measurement times short, the cascaded
approach oﬀered accurate localisation and low SAR. The SNR was
increased 1.6-fold compared to single-slice acquisition, but theoretical
predictions were not entirely fulﬁlled. This could be explained by the
larger brain coverage that makes our acquisitions more prone to B0/
B1
+-inhomogeneities as well as partial volume eﬀects from ventricles,
compared to single-slice MRSI. Traditional HSI using superimposed
Fig. 6. A comparison of the metabolic maps for tNAA, tCr, tCho, Glx and Ins resulting from measurements with 64×64- and 100×100 matrix size (protocols 4SL_M64_ TR200 and
4SL_M100_ TR200, see Tbl. 1) for one volunteer shows that both allow the creation of high-quality 3D-MRSI maps. The higher resolution allows a clearer separation of anatomical
regions and shows more correspondence to the gyri, especially in the upper slices, but also display more artefacts, as seen in the frontal regions of the slices 1 and 2. The colours from
cold to warm indicate higher relative concentrations.
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pulses is impractical at ≥7 T, and thus, HSI has so far not found wide
application, although cascaded HSI was shown to overcome major
technical problems at 7 T (Goelman et al., 2007). In comparison, HSI
was recently employed at 3 T, e.g., for multi-slice rosette-trajectory
MRSI (Schirda et al., ISMRM 2015, Nr. 0987).
4.1.5. Lipid artefact removal
Lipid removal during data processing using L2-regularisation
(Bilgic et al., 2013), as in our study, can reduce lipid signals by a lipid
suppression factor (LSF) of 9–10. This method is computationally
demanding, but does not negatively aﬀect SAR, measurement time, or
localisation and does not require additional measurement equipment.
In comparison, other lipid suppression methods at 7 T were able to
reach higher LSFs, but had some drawbacks. FIDLOVS (Henning et al.,
2009) outer volume suppression achieved an LSF of 25, but prolonged
the minimum TR to 5 s to stay within SAR constraints. SWAMP water/
lipid suppression (Boer et al., 2011), limited to an ROI, featured an LSF
of 4–5. Non-selective DIR-based lipid suppression (Hangel et al., 2015)
reached an LSF of 13, but sacriﬁced ~50% of the SNR and increased
the minimum TR. Spatial-spectral outer volume suppression
(Balchandani and Spielman, 2008) resulted in an LSF of 7, but also a
loss of metabolite signal between 3.2 and 4.7 ppm in the brain
periphery. Slice-selective hyperbolic secant pulses combined with
dynamic B0-shimming (Boer et al., 2012), allowed an LSF of ~30 but
the setup was time-consuming (i.e., ~10 min). Using additional hard-
ware, such as an eight-channel transmission array for ring-shaped B1
+-
excitation of subcutaneous lipids (Hetherington et al., 2010), allowed
an LSF of 58, while an additional crusher coil activated during the TE
(Boer et al., 2015) achieved LSFs of 20–70.
4.1.6. Ultra-high resolution metabolite mapping
The resulting metabolite maps of the brain show unmatched detail
that allows the study of small focal regions. On the NAA maps the
hemispheres, ventricles, gyri and cerebrospinal ﬂuid (CSF) are clearly
distinguishable. Cho- and Glx-maps show the expected strong GM/WM
contrast. The clearly visible Cho hotspot in the mesial frontal grey
matter is likely linked to the cingulate gyrus (Degaonkar et al., 2005).
4.2. Advantages and limitations
The main advantages of the proposed UHR-FID-MRSI approach
are the high in-plane resolution and full slice coverage without ROI
Fig. 7. Metabolic maps (tNAA, tCho, Glx) of slice 2 for all ﬁve volunteers measured with the 4SL_M100_TR200 protocol in 17 min as well as an example of the typical placement of the
MRSI matrix. The quality is similar over all measurements (like the GM/WM contrast for the tCho and Glx maps), but three of the volunteers’maps show signal inhomogeneity from one
side to the other that can be removed by the calculation of metabolic ratios (see Fig. 8). The colours from cold to warm indicate higher relative concentrations.
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restrictions, but within clinically feasible scan times. The resulting
small voxel size reduces partial volume eﬀects substantially. HSI
extends this method to a limited number of slices while increasing
the available SNR without the drawbacks associated with phase
encoding in the z-direction. A major disadvantage of the cascaded
approach is the slightly diﬀerent TEs or ADs for diﬀerent slices, which
may be overcome by the design of recently proposed multi-band RF
pulses (Feinberg and Setsompop, 2013; Koopmans et al., 2013).
CAIPIRINHA acceleration with imaging prescans as auto-calibra-
tion data is very eﬃcient at 7 T with a 32-channel array coil (Hangel
et al., 2015). The exact resolution and measurement time for a desired
protocol are a trade-oﬀ between SNR/spectral quality, measurement
time, and resolution. This makes UHR-MRSI a ﬂexible clinical research
tool for matrix sizes from 64×64 to 128×128 and one to four slices.
Slice placement is limited by ﬁeld inhomogeneities, particularly in
B0, while it is less sensitive to B1
+ errors than other MRSI approaches.
If no additional B0 shimming (Hetherington et al., 2014; Pan et al.,
2012; Stockmann et al., 2015) is used, our approach is, thus, currently
limited to regions at the level of the ventricles and above. Due to the
desired short measurement times, HSI for multi-slice MRSI is limited
to a maximum of four slices, which is suﬃcient to cover the brain from
the ventricles upward, with an ~4 cm thick slab. In combination with
spatial-spectral sampling methods, PI could achieve far higher accel-
eration, which would oﬀer superior brain coverage (Sabati et al., 2014;
Tsai et al., 2008).
A reduced readout duration can lead to truncation artefacts of the
FID, which could occur when T2
*s increase due to a better B0-shim.
This could bias the quantiﬁcation of low abundant (J-coupled)
metabolites.
Motion reduces spectral quality and leads to substantial lipid
artefacts. Movement artefacts can be reduced by keeping scan times
short, which is essential for noncompliant subjects. Real-time motion
correction can further improve data quality (Bogner et al., 2014, 2013).
In our study we removed lipid artefacts by L2-regularisation, which
avoids the drawbacks of other lipid suppression schemes (see 4.1.5.).
4.3. Outlook
The introduction of additional hardware- or software-based meth-
ods will further improve data quality. Possible technical improvements
include higher-order B0-shims (Hetherington et al., 2014; Pan et al.,
2012), dynamic shims (Boer et al., 2012; Duerst et al., 2015), or
enhanced B0-shimming algorithms (Fillmer et al., 2015), as well as
B1
+-shimming with parallel transmit systems (Boer et al., 2012; Emir
et al., 2012). Real-time motion correction (Bogner et al., 2013) will
further increase the reliability of our MRSI acquisition strategy. Better
gradient coils and reconstruction software will enhance the perfor-
mance of accelerated high-resolution MRSI. Most of these improve-
ments will improve SNR, which can be translated into higher accel-
eration, and thus, reduced measurement times or increased (multi-
slice) brain coverage.
In any case, UHR-MRSI could be applied to clinical research
questions, such as previously demonstrated for glioma (Li et al.,
2015)(Chadzynski et al., ISMRM 2015, Nr. 0763), Multiple Sclerosis
(Srinivasan et al., 2010), brain injury (Hetherington et al., 2014),
Adrenoleukodystrophy (Ratai et al., 2008), and the study of
Alzheimer's disease, Parkinson's disease, and Epilepsy (Pan et al.,
2013). Apart from these clinical applications, UHR-MRSI in volunteers
would allow a highly detailed biochemical reference “atlas” to be
established to aid future brain research and study of the normal aging
brain (Lecocq et al., 2015).
5. Conclusions
We successfully demonstrated that the beneﬁts of 7 T systems, i.e.,
improved SNR and increased spectral dispersion, can be translated into
clinically feasible multi-slice FID-MRSI with ultra-high spatial resolu-
tion mapping ( < 2×2 mm2 with a 128×128 matrix) of several impor-
tant chemical compounds. This will facilitate the application of MRSI
to clinical and neuro-scientiﬁc research problems where the visualiza-
tion of small details is mandatory (e.g., small Multiple Sclerosis
lesions). In summary, UHR-MRSI within clinically applicable measure-
Fig. 8. Detailed view of all four slices for one of the volunteers measured with the 4SL_M100_ TR200 protocol in 17 min, including metabolite (tNAA, tCr, tCho, Glx, and Ins) and
metabolic ratio maps (tCr/tNAA, tCho/tNAA, Glx/tNAA, Ins/tNAA). Structures like ventricles and gyri are visible on the metabolic maps. On the ratio maps, the expected change in
ratios due to the increase of grey matter in the slice can be clearly seen. The colours from cold to warm indicate higher relative concentrations.
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ment times, as presented here, is a powerful imaging tool that shows
the beneﬁts that ≥7 T systems oﬀer.
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